The impact of circulating 25-hydroxyvitamin D and vitamin D receptor variation on leukemia-lymphoma outcome: Molecular and cytogenetic study

Zahraa A. Abdulrazaq; Mushtak T.S. Al-Ouqaili; Nabeel M. Talib

doi:10.1016/j.sjbs.2023.103882

Citations

391

Views

Abstract not available for this publication.

Cite this Article (APA)

Zahraa, A. A., Mushtak, T. A., Nabeel, M. T. (2024). The impact of circulating 25-hydroxyvitamin D and vitamin D receptor variation on leukemia-lymphoma outcome: Molecular and cytogenetic study. Saudi Journal of Biological Sciences. https://doi.org/10.1016/j.sjbs.2023.103882

Emad Abada; Abdullah Mashraqi; Yosra Modafer; Mohamed A. Al Abboud; A. El-Shabas · 2024

cites

401

An overview of multiple myeloma: A monoclonal plasma cell malignancy’s diagnosis, management, and tr…

Maisa Siddiq Abduh · 2024

cites

401

New eco-friendly trends to produce biofuel and bioenergy from microorganisms: An updated review

Nidal M. Zabermawi; Faten A.S. Alsulaimany; Mohamed T. El-Saadony; Khaled A. El- · 2025

cites

397

Phytochemical analysis, GC–MS profile and determination of antibacterial, antifungal, anti-inflammat…